tiprankstipranks

Brian Markison Insider Profile

4 Followers
Brian Markison, Director at Immunomedics, holds 152.83K shares in Lantheus (Ticker: LNTH), holds 2.98M shares in RVL Pharmaceuticals (Ticker: RVLPQ), holds 90.79K shares in Immunomedics (Ticker: IMMU).
tipranks
Brian Markison

Brian Markison
Immunomedics (IMMU)
Director

Ranked #88,884 out of 98,501 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-43.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
99.70%
0.30%
0.00%
0.00%
A breakdown of Brian Markison's holdings

Insider Roles

Lantheus
(LNTH)
CEO, Director
RVL Pharmaceuticals
(RVLPQ)
CEO, Director
Organogenesis Holdings
(ORGO)
Director
Altimmune
(ALT)
Director
Roles that Brian Markison holds in companies

Most Profitable Insider Trade

Stock:
Immunomedics
(IMMU)
Rating:Informative Buy
Date:Nov 21, 2017 - Nov 21, 2018
Return:0.00%
The most profitable trade made by Brian Markison

Brian Markison's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMMU
Immunomedics
Nov 21, 2017
Informative Buy
47.40K
$7.98M
Lantheus
Mar 05, 2024
CEO, Director
Uninformative Buy
$9.75M
Organogenesis Holdings
Director
RVL Pharmaceuticals
Aug 09, 2022
CEO, Director
Informative Buy
1.32M
$29.76K
Altimmune
Director
$0.00
~ALR
Alere Inc
Oct 03, 2017
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Brian Markison's performance on stock

Brian Markison insider profile FAQ

What is the percentage of profitable transactions made by Brian Markison?
The percentage of profitable transactions made by Brian Markison is 0%.
    What is the average return per transaction made by Brian Markison?
    The average return per transaction made by Brian Markison is -43.30%.
      What stocks does Brian Markison hold?
      Brian Markison holds: IMMU, LNTH, ORGO, RVLPQ, ALT, ~ALR stocks.
        What was Brian Markison’s latest transaction?
        Brian Markison latest transaction was an Uninformative Buy of ―.
          What was Brian Markison's most profitable transaction?
          Brian Markison’s most profitable transaction was an Informative Buy of IMMU stock on November 21, 2017. The return on the trade was 0.00%.
            What is Brian Markison's role in Immunomedics?
            Brian Markison's role in Immunomedics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.